Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving transferase
Reexamination Certificate
2005-01-18
2005-01-18
Saidha, Tekchand (Department: 1652)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving transferase
C435S194000, C435S007600, C435S007720
Reexamination Certificate
active
06844167
ABSTRACT:
This invention provides the genes encoding the RNA triphosphatase and RNA guanylyltransferase of the malaria parasitePlasmodium falciparumand the catalytically active recombinant RNA triphosphatase and RNA guanylyltransferase enzymes. These enzymes form the basis of activity inhibition assays to identify molecules that specifically target the formation of the mRNA 5′ cap in unicellular eukaryotic parasites.
REFERENCES:
patent: 6107040 (2000-08-01), Shuman
patent: 6232070 (2001-05-01), Shuman
patent: 6420163 (2002-07-01), Shuman
patent: 6451583 (2002-09-01), Shuman et al.
Gardner M.J. et al. Genome sequence of the human malaria parasitePlasmodium falciparum, Nature, 2002, 419, 498-511.
Ho Chong Kiong
Shuman Stewart
Adler Benjamin Aaron
Saidha Tekchand
Walicka Malgorzata
LandOfFree
Pharmacological targeting of mRNA cap formation for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmacological targeting of mRNA cap formation for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacological targeting of mRNA cap formation for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3390890